Medtronic Sees 9 Percent Organic Revenue Growth in Fiscal 2022

 Medtronic PLC said Thursday that it estimates organic sales growth will drive a higher adjusted profit in the coming fiscal year.

The Ireland-based medical-technology company forecast organic revenue growth of 9%, compared with full-year revenue of $30.12 billion in fiscal 2021. It forecast adjusted earnings of $5.60 to $5.75 a share.

Analysts surveyed by FactSet were anticipating fiscal 2022 revenue of $32.67 billion and adjusted earnings of $5.75 a share.

https://www.marketscreener.com/quote/stock/MEDTRONIC-PLC-20661655/news/Medtronic-Sees-9-Percent-Organic-Revenue-Growth-in-Fiscal-2022-33365880/